{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:13:24Z","timestamp":1789010004957,"version":"build-2803163510"},"reference-count":179,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bbcan.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T03:03:31Z","timestamp":1506135811000},"page":"484-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cancer as an ecomolecular disease and a neoplastic consortium"],"prefix":"10.1016","volume":"1868","author":[{"given":"Santiago","family":"Ram\u00f3n y Cajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Hernandez-Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"De Mattos-Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lorent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-2695","authenticated-orcid":false,"given":"Trond","family":"Aasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne-Marie","family":"Postovit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Topisirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.5858\/arpa.2012-0263-RA","article-title":"Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer\/American Thoracic Society\/European respiratory society classification","volume":"137","author":"Travis","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0010","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1038\/srep04709","article-title":"Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression","volume":"4","author":"Denisov","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0015","series-title":"Rosai and Ackerman's Surgical Pathology","author":"Rosai","year":"2012"},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lungcan.2015.06.022","article-title":"Prognostic value of the new IASLC\/ATS\/ERS classification of clinical stage IA lung adenocarcinoma","volume":"90","author":"Murakami","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0025","series-title":"DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology","author":"DeVita","year":"2014"},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrd.2016.3","article-title":"Combination therapies in oncology","volume":"15","author":"Webster","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bbcan.2017.09.004_bb0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6206","key":"10.1016\/j.bbcan.2017.09.004_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc3712","article-title":"Turning ecology and evolution against cancer","volume":"14","author":"Korolev","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"suppl 6(6)","key":"10.1016\/j.bbcan.2017.09.004_bb0050","article-title":"Spatial and temporal cancer evolution: causes and consequences of tumour diversity","volume":"14","author":"Hiley","year":"2014","journal-title":"Clin. Med."},{"issue":"6282","key":"10.1016\/j.bbcan.2017.09.004_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular exosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/0008-5472.CAN-15-1907","article-title":"Single-Cell sequencing for precise cancer research: Progress and prospects","volume":"76","author":"Zhang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0065","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1038\/srep04709","article-title":"Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression","volume":"4","author":"Denisov","year":"2014","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr3658","article-title":"Breast cancer intra-tumor heterogeneity","volume":"16","author":"Martelotto","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early stage lung cancer evolution","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the Evolution of Non\u2013Small-Cell Lung Cancer","author":"Jamal-Hanjani","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng.2891","article-title":"Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing","volume":"46","author":"Gerlinger","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0090","series-title":"The Hallmarks of Cancer","first-page":"57","volume":"100(7)","author":"Hanahan","year":"2000"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"7381","key":"10.1016\/j.bbcan.2017.09.004_bb0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.devcel.2016.08.012","article-title":"Cell competition and its role in the regulation of cell fitness from development to cancer","volume":"38","author":"Di Gregorio","year":"2016","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0110","first-page":"E6496","article-title":"Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution","volume":"113","author":"Ling","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A Big Bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ng.3231","article-title":"Big Bang and context-driven collapse","volume":"47","author":"Robertson-Tessi","year":"2015","journal-title":"Nat Genet"},{"issue":"July","key":"10.1016\/j.bbcan.2017.09.004_bb0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrg3767","article-title":"Expanding the computational toolbox for mining cancer genomes","volume":"15","author":"Ding","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0130","first-page":"1","article-title":"The recurrent architecture of tumour initiation, progression and drug sensitivity","author":"Califano","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"7467","key":"10.1016\/j.bbcan.2017.09.004_bb0135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature12624","article-title":"Tumour heterogeneity and cancer cell plasticity","volume":"501","author":"Meacham","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10555-017-9660-6","article-title":"BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma","volume":"36","author":"Queirolo","year":"2017","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0150","first-page":"515","article-title":"The dynamic control of signal transduction networks in cancer cells","volume":"15","author":"Kolch","year":"2015","journal-title":"Nat. Publ. Group"},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0155","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran","year":"2014","journal-title":"Mol. Cell"},{"issue":"5935","key":"10.1016\/j.bbcan.2017.09.004_bb0160","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1171837","article-title":"The increasing complexity of the cancer stem cell paradigm","volume":"324","author":"Rosen","year":"2009","journal-title":"Science"},{"issue":"6464","key":"10.1016\/j.bbcan.2017.09.004_bb0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0175","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"3983","article-title":"Prospective identification of tumorigenic breast cancer cells","author":"Al-Hajj","year":"2003"},{"issue":"November","key":"10.1016\/j.bbcan.2017.09.004_bb0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"issue":"7123","key":"10.1016\/j.bbcan.2017.09.004_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"issue":"7654","key":"10.1016\/j.bbcan.2017.09.004_bb0190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature22334","article-title":"A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma","volume":"545","author":"Tammela","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/157488812799859838","article-title":"Microenvironmental Regulation of Cancer Stem Cell Phenotypes","volume":"7","author":"Quail","year":"2012","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0200","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/bcr2449","article-title":"Dynamic regulation of CD24 and the invasive, CD44posCD24negphenotype in breast cancer cell lines","volume":"11","author":"Meyer","year":"2009","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0205","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0210","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"a. The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.bbcan.2017.09.004_bb0215","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-10-3035","article-title":"EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells","volume":"71","author":"Tellez","year":"2011","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.bbcan.2017.09.004_bb0220","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1073\/pnas.1004900107","article-title":"Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes","volume":"107","author":"Taube","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0230","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biocel.2012.12.021","article-title":"Nodal signalling in embryogenesis and tumourigenesis","volume":"45","author":"Quail","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tacking the cancer stem cells - what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2014.06.004","article-title":"A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms","volume":"31","author":"Cojoc","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"19","key":"10.1016\/j.bbcan.2017.09.004_bb0245","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1073\/pnas.1102454108","article-title":"Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state","volume":"108","author":"Chaffer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0250","series-title":"Pushing the Limits of Targeted Therapy in Chronic Myeloid Leukaemia","volume":"12","author":"Hare","year":"2012"},{"issue":"7330","key":"10.1016\/j.bbcan.2017.09.004_bb0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0260","series-title":"Human Chronic Myeloid Leukemia Stem Cells Are Insensitive to Imatinib Despite Inhibition of BCR-ABL Activity","volume":"121","author":"Corbin","year":"2011"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0265","series-title":"Chronic Myeloid Leukemia Stem Cells Possess Multiple Unique Features of Resistance to BCR-ABL Targeted Therapies","first-page":"926","author":"Jiang","year":"2007"},{"issue":"11","key":"10.1016\/j.bbcan.2017.09.004_bb0270","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1158\/0008-5472.CAN-15-2962","article-title":"Darwinian dynamics of intratumoral heterogeneity: Not solely random mutations but also variable environmental selection forces","volume":"76","author":"Lloyd","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0275","series-title":"Growth Factor-induced MAPK Network Topology Shapes Erk Response Determining PC-12 Cell Fate","volume":"9","author":"Santos","year":"2007"},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1004115","article-title":"Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer","volume":"11","author":"Banerji","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0290","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1038\/srep06566","article-title":"Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling","volume":"4","author":"Dai","year":"2014","journal-title":"Sci Rep"},{"issue":"7382","key":"10.1016\/j.bbcan.2017.09.004_bb0295","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0300","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0305","first-page":"2259","article-title":"Tumor Heterogeneity","volume":"44","author":"Heppner","year":"1984","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0310","first-page":"91","article-title":"Therapeutic implications of tumor heterogeneity","volume":"16","author":"Heppner","year":"1989","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0315","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2017.09.004_bb0320","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc3971","article-title":"Tumorigenesis: it takes a village","volume":"15","author":"Tabassum","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2015.00143","article-title":"Ecological perspectives on synthetic biology: insights from microbial population biology","volume":"6","author":"Escalante","year":"2015","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0330","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1073\/pnas.1421839112","article-title":"Only three driver gene mutations are required for the development of lung and colorectal cancers","volume":"112","author":"Tomasetti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.bbcan.2017.09.004_bb0335","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMp1508811","article-title":"The path to cancer - three strikes and you're out","volume":"373","author":"Vogelstein","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0340","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.celrep.2014.06.045","article-title":"Heterogeneous tumor subpopulations cooperate to drive invasion","volume":"8","author":"Chapman","year":"2014","journal-title":"Cell Rep."},{"issue":"6282","key":"10.1016\/j.bbcan.2017.09.004_bb0345","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.aaf6546","article-title":"A collective route to metastasis: Seeding by tumor cell clusters","volume":"352","author":"Cheung","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0350","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbcan.2017.09.004_bb0355","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/2159-8290.CD-15-0120","article-title":"Pancreatic cancer metastases harbor evidence of polyclonality","volume":"5","author":"Maddipati","year":"2015","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0360","doi-asserted-by":"crossref","first-page":"201508541","DOI":"10.1073\/pnas.1508541113","article-title":"Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters","volume":"113","author":"Cheung","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0370","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"issue":"6282","key":"10.1016\/j.bbcan.2017.09.004_bb0375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aaf7300","article-title":"How neutrophils promote metastasis","volume":"352","author":"de Visser","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood-2016-01-636399","article-title":"Metastasis: new functional implications of platelets and megakaryocytes","volume":"128","author":"Leblanc","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0385","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0390","first-page":"1","article-title":"Feedback control in a stem cell model can cause an Allee effect","volume":"78","author":"Hillen","year":"2011","journal-title":"Bull. Math. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0395","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bcp.2012.10.001","article-title":"Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting","volume":"85","author":"Persano","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbcan.2017.09.004_bb0400","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc3597","article-title":"Unravelling cancer stem cell potential","volume":"13","author":"Beck","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0405","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet."},{"issue":"83","key":"10.1016\/j.bbcan.2017.09.004_bb0415","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4829106","article-title":"Aggressiveness niche: Can it be the foster ground for cancer metastasis precursors?","volume":"2016","author":"Elshamy","year":"2016","journal-title":"Stem Cells Int."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0430","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00207.2015","article-title":"Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia","volume":"309","author":"Noman","year":"2015","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"6282","key":"10.1016\/j.bbcan.2017.09.004_bb0435","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0440","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"April","key":"10.1016\/j.bbcan.2017.09.004_bb0445","first-page":"1","article-title":"Advancing cancer therapy with present and emerging immuno-oncology approaches","volume":"7","author":"Kamta","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0450","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases\u2014elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0455","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1172\/JCI80004","article-title":"From mice to humans: developments in cancer immunoediting","volume":"125","author":"MWL","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0460","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-16-1022","article-title":"Epigenomic promoter alterations amplify gene isoform and immunogenic diversity in gastric adenocarcinoma","author":"Qamra","year":"2017","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.bbcan.2017.09.004_bb0465","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrn3962","article-title":"From the neuron doctrine to neural networks","volume":"16","author":"Yuste","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0470","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1752-0509-7-14","article-title":"Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties","volume":"7","author":"Liu","year":"2013","journal-title":"BMC Syst. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0475","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2105-12-86","article-title":"Joint analysis of transcriptional and post- transcriptional brain tumor data: searching for emergent properties of cellular systems","volume":"12","author":"Fronza","year":"2011","journal-title":"BMC Bioinf."},{"issue":"6282","key":"10.1016\/j.bbcan.2017.09.004_bb0480","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbcan.2017.09.004_bb0485","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0490","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1158\/2159-8290.CD-15-1283","article-title":"Tumor heterogeneity and Lesion-specific response to targeted therapy in colorectal cancer","volume":"6","author":"Russo","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0495","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1038\/ncomms6499","article-title":"Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations","volume":"5","author":"Gatenby","year":"2014","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0500","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.molcel.2015.05.008","article-title":"The cancer cell map initiative: defining the Hallmark networks of cancer","volume":"58","author":"Krogan","year":"2015","journal-title":"Mol. Cell"},{"issue":"7279","key":"10.1016\/j.bbcan.2017.09.004_bb0505","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The transcriptional network for mesenchymal transformation of brain tumours","volume":"463","author":"Carro","year":"2010","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1001906","article-title":"Tracking genomic cancer evolution for precision medicine: the lung TRACERx study","volume":"12","author":"Jamal-Hanjani","year":"2014","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0515","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/1078-0432.CCR-14-1429","article-title":"Translational implications of tumor heterogeneity","volume":"21","author":"Jamal-Hanjani","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0520","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/pme.11.7","article-title":"The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?","volume":"8","author":"Lillie","year":"2011","journal-title":"Pers. Med."},{"issue":"67","key":"10.1016\/j.bbcan.2017.09.004_bb0525","article-title":"An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer","volume":"4","author":"Chari","year":"2010","journal-title":"BMC Syst. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0530","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrclinonc.2014.6","article-title":"Cancer Systems Biology: a peek into the future of patient care?","volume":"11","author":"Werner","year":"2014","journal-title":"Nat. Rev. Clin. Oncol. Nature Publishing Group"},{"issue":"11","key":"10.1016\/j.bbcan.2017.09.004_bb0535","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.str.2012.10.002","article-title":"Structural data in synthetic biology approaches for studying general design principles of cellular signaling networks","volume":"20","author":"Kiel","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0540","series-title":"Cross-Disciplinary Detection and Analysis of Network Motifs","first-page":"49","author":"Tran","year":"2015"},{"issue":"7544","key":"10.1016\/j.bbcan.2017.09.004_bb0545","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature14210","article-title":"Systems biology: defiant daughters and coordinated cousins","volume":"519","author":"Hilfinger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0550","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biosystems.2005.05.014","article-title":"Cancer: a systems biology disease","volume":"83","author":"Hornberg","year":"2006","journal-title":"Mol. BioSyst."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0555","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.semcancer.2011.04.004","article-title":"Systems biology beyond networks: Generating order from disorder through self-organization","volume":"21","author":"Saetzler","year":"2011","journal-title":"Semin. Cancer Biol."},{"issue":"5924","key":"10.1016\/j.bbcan.2017.09.004_bb0560","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1168978","article-title":"Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling","volume":"324","author":"Ingolia","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0565","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1038\/ncomms12915","article-title":"Comparative survey of the relative impact of mRNA features on local ribosome profiling read density","volume":"7","author":"O'Connor","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0570","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0575","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy","volume":"6","author":"Alix-Panabi\u00e8res","year":"2016","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0580","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrclinonc.2013.80","article-title":"Circulating tumour cells and cell-free DNA as tools for managing breast cancer","volume":"10","author":"De Mattos-Arruda","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"136","key":"10.1016\/j.bbcan.2017.09.004_bb0585","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"7447","key":"10.1016\/j.bbcan.2017.09.004_bb0590","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0595","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0600","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1038\/ncomms9760","article-title":"Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer","volume":"6","author":"Murtaza","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0605","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-13-0465","article-title":"Addressing genetic tumor heterogeneity through computationally predictive combination therapy","volume":"4","author":"Zhao","year":"2014","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0610","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13059-014-0463-6","article-title":"Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope","volume":"15","author":"Aparicio","year":"2014","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2017.09.004_bb0615","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2217\/fon.14.122","article-title":"Tumor heterogeneity-based resistance guides personalized cancer medicine","volume":"10","author":"Lianos","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-genet-120213-092314","article-title":"Cancer: evolution within a lifetime","volume":"48","author":"Gerlinger","year":"2014","journal-title":"Annu. Rev. Genet."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0625","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/0008-5472.CAN-13-2357-T","article-title":"Genetic and phenotypic diversity in breast tumor metastases","volume":"74","author":"Almendro","year":"2014","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0630","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/labinvest.2012.91","article-title":"Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue","volume":"92","author":"Potts","year":"2012","journal-title":"Lab Investig"},{"issue":"12","key":"10.1016\/j.bbcan.2017.09.004_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a011528","article-title":"Principles of translational control: an overview","volume":"4","author":"Hershey","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0640","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0645","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev-biochem-060713-035802","article-title":"The scanning mechanism of eukaryotic translation initiation","volume":"83","author":"Hinnebusch","year":"2014","journal-title":"Annu. Rev. Biochem."},{"issue":"12","key":"10.1016\/j.bbcan.2017.09.004_bb0650","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.tcb.2016.06.005","article-title":"Translation initiation factors: reprogramming protein synthesis in cancer","volume":"26","author":"Chu","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"6980","key":"10.1016\/j.bbcan.2017.09.004_bb0655","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bbcan.2017.09.004_bb0660","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1158\/0008-5472.CAN-06-0419","article-title":"Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo","volume":"66","author":"Wendel","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0665","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/1078-0432.CCR-06-1560","article-title":"4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis","volume":"13","author":"Rojo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0670","series-title":"eIF4F is a Nexus of Resistance to Anti-BRAF and Anti-MEK Cancer Therapies","author":"Mateus","year":"2014"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0675","series-title":"Formation of the eIF4F Translation \u2013 Initiation Complex Determines Sensitivity to Anticancer Drugs Targeting the EGFR and HER2 Receptors","first-page":"4068","volume":"71(12)","author":"Allal","year":"2011"},{"issue":"37","key":"10.1016\/j.bbcan.2017.09.004_bb0680","doi-asserted-by":"crossref","first-page":"E699","DOI":"10.1073\/pnas.1108237108","article-title":"PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis","volume":"108","author":"Ilic","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0685","series-title":"eIF4E\/4E\u2013BP Ratio Predicts the Efficacy of mTOR Targeted Therapies","first-page":"6468","volume":"72(24)","author":"Alain","year":"2012"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0690","series-title":"Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mTOR kinase inhibitors in aggressive B-cell lymphomas","author":"Bi","year":"2017"},{"issue":"Pt 4","key":"10.1016\/j.bbcan.2017.09.004_bb0695","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1242\/jcs.137588","article-title":"Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation","volume":"127","author":"Cope","year":"2014","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0700","first-page":"1","article-title":"Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1","volume":"9","author":"Mallya","year":"2014"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0705","series-title":"The 4E\u2013BP \u2013 eIF4E Axis Promotes Rapamycin-sensitive Growth and Proliferation in Lymphocytes","first-page":"1","volume":"9(430)","author":"So","year":"2016"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0710","series-title":"The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma","first-page":"135","author":"Zhan","year":"2015"},{"issue":"16","key":"10.1016\/j.bbcan.2017.09.004_bb0715","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1158\/0008-5472.CAN-07-0881","article-title":"4E-binding protein 1: a key molecular \u201cfunnel factor\u201d in human cancer with clinical implications","volume":"67","author":"Armengol","year":"2007","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2017.09.004_bb0720","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cncr.22195","article-title":"Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer","volume":"107","author":"Castellvi","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2017.09.004_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0123352","article-title":"Phosphorylation of eIF4E confers resistance to cellular stress and DNA-damaging agents through an interaction with 4E-T: a Rationale for novel therapeutic approaches","volume":"10","author":"Mart\u00ednez","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbcan.2017.09.004_bb0730","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/cam4.817","article-title":"peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas","volume":"5","author":"Martinez-Saez","year":"2016","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0735","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1158\/0008-5472.CAN-07-5635","article-title":"Targeting the eukaryotic translation initiation factor 4E for cancer therapy","volume":"68","author":"Graff","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2017.09.004_bb0740","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/0008-5472.CAN-14-2789","article-title":"Targeting the eIF4F translation initiation complex: a critical nexus for cancer development","volume":"75","author":"Pelletier","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0745","series-title":"Protein Synthesis is Resistant to Rapamycin And Constitutes a Promising Therapeutic Target in Acute Myeloid Leukemia","first-page":"1","volume":"114(8)","author":"Tamburini","year":"2017"},{"issue":"11","key":"10.1016\/j.bbcan.2017.09.004_bb0750","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12094-014-1203-9","article-title":"The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets","volume":"16","author":"Ramon","year":"2014","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0755","article-title":"Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model","volume":"118","author":"Bordeleau","year":"2008"},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0760","first-page":"861","article-title":"eIF4F suppression in breast cancer affects maintenance and progression","volume":"32","author":"Nasr","year":"2012","journal-title":"Nat. Publ. Group"},{"issue":"24","key":"10.1016\/j.bbcan.2017.09.004_bb0765","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/0008-5472.CAN-15-0885","article-title":"SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex","volume":"75","author":"Feng","year":"2015","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0770","first-page":"1337","article-title":"The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model","volume":"39","author":"Pons","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0775","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccr.2005.05.024","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"7","author":"Joyce","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0780","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-016-2467-x","article-title":"Fibroblast activation in cancer: when seed fertilizes soil","author":"Kuzet","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0785","series-title":"Annals of the New York Academy of Sciences","first-page":"1","article-title":"Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma","author":"Wolchok","year":"2013"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0790","first-page":"234","article-title":"Pembrolizumab: first in class for treatment of metastatic melanoma","author":"Barnhart","year":"2015","journal-title":"J. Adv. Practition. Oncol."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0795","first-page":"313","article-title":"Clinical utility of nivolumab in the treatment of advanced melanoma","author":"Asmar","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0800","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceb.2017.05.007","article-title":"Translational control and the cancer cell response to stress","volume":"45","author":"Robichaud","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2017.09.004_bb0805","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbagrm.2014.11.002","article-title":"Stress-mediated translational control in cancer cells","volume":"1849","author":"Leprivier","year":"2015","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0810","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BST20150126","article-title":"Signalling to eIF4E in cancer","volume":"43","author":"Siddiqui","year":"2015","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.bbcan.2017.09.004_bb0815","first-page":"1909","article-title":"Mitogen-activated protein kinases activate the serine\/threonine kinases Mnk1 and Mnk2","volume":"16","author":"Waskiewicz","year":"1997"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0820","series-title":"MNK1, a New MAP Kinase-activated Protein Kinase, Isolated by a Novel Expression Screening Method for Identifying Protein Kinase Substrates","first-page":"1921","volume":"16(8)","author":"Fukunaga","year":"1997"},{"issue":"32","key":"10.1016\/j.bbcan.2017.09.004_bb0825","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.1005320107","article-title":"eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression","volume":"107","author":"Furic","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.bbcan.2017.09.004_bb0830","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/onc.2014.146","article-title":"Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3","volume":"34","author":"Robichaud","year":"2015","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0835","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1172\/JCI85183","article-title":"Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers","volume":"126","author":"Lock","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bbcan.2017.09.004_bb0840","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/0008-5472.CAN-10-3298","article-title":"Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases","volume":"71","author":"Konicek","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0845","series-title":"MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma","volume":"14","author":"Bell","year":"2016"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0850","series-title":"Targeting of the MNK \u2013 eIF4E Axis in Blast Crisis Chronic Myeloid Leukemia Inhibits Leukemia Stem Cell Function","first-page":"2298","author":"Lim","year":"2013"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0855","series-title":"Inhibition of Mnk Kinase Activity by Cercosporamide and Suppressive Effects on Acute Myeloid Leukemia Precursors","first-page":"3675","volume":"121(18)","author":"Altman","year":"2017"},{"issue":"6","key":"10.1016\/j.bbcan.2017.09.004_bb0860","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/eva.12232","article-title":"Cancer: An emergent property of disturbed resource-rich environments? Ecology meets personalized medicine","volume":"8","author":"Ducasse","year":"2015","journal-title":"Evol. Appl."},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/eva.12021","article-title":"Applying ecological and evolutionary theory to cancer: a long and winding road","volume":"6","author":"Thomas","year":"2013","journal-title":"Evol. Appl."},{"issue":"NOV","key":"10.1016\/j.bbcan.2017.09.004_bb0870","first-page":"1","article-title":"Impact of spatial distribution on the development of mutualism in microbes","volume":"5","author":"Kov\u00e1cs","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbcan.2017.09.004_bb0875","series-title":"Poincar\u00e9 and the three body problem","author":"Barrow-Green","year":"1997"},{"issue":"3","key":"10.1016\/j.bbcan.2017.09.004_bb0880","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/gm543","article-title":"Choice of transcripts and software has a large effect on variant annotation","volume":"6","author":"DJ","year":"2014","journal-title":"Genome Med."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2017.09.004_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-2789(97)00252-2","article-title":"On the optimailty of the Ott-Grebogi-Yorke control scheme","volume":"116","author":"Epureanu","year":"1998","journal-title":"Physica D"},{"issue":"1","key":"10.1016\/j.bbcan.2017.09.004_bb0890","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41598-017-04075-z","article-title":"Breast Cancer Multi-classification from histopathological images with structured deep learning model","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bbcan.2017.09.004_bb0895","doi-asserted-by":"crossref","first-page":"45938","DOI":"10.1038\/srep45938","article-title":"Relevance of deep learning to facilitate the diagnosis of HER2 status in Breast Cancer","volume":"7","author":"Vandenberghe","year":"2017","journal-title":"Sci Rep"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17300525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17300525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T06:40:00Z","timestamp":1535352000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X17300525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0304419X17300525"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.09.004","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer as an ecomolecular disease and a neoplastic consortium","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}